December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment ↗
Via Stocktwits
Tickers APIE DFAX NVS
Exposures Product Safety
News headline image
Hemostemix Receives FDA Support for Its Basket Protocol Approach
Via Newsfile
Tickers HMTXF TSX-V:HEM
Exposures Product Safety
News headline image
The Truth Engine: How Prediction Markets Became the New Foundation for Global Capital
Via PredictStreet
Topics Artificial Intelligence Bonds Derivatives
Tickers COIN HOOD ICE
Exposures Artificial Intelligence Debt Markets Derivatives
Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗
Via Stocktwits
Tickers IRON LLY SNY
Exposures Product Safety
REMSleep Receives Expanded FDA 510(k) Clearance for DeltaWave Nasal Pillow System
Via TheNewswire.com
Tickers RMSL
Exposures Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
Via NewMediaWire
Tickers AQST
Exposures Product Safety
News headline image
Kaplan Fox &amp; Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations
Via TheNewswire.com
Tickers AQST
Exposures Product Safety
News headline image
S&P 500 Ascends to Historic Peaks: Stimulus and AI Rebound Fuel January Rally
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Tickers AAPL BAC DELL FIVE GM GOOGL
Exposures Artificial Intelligence Economy Financial
News headline image
Lululemon at the Crossroads: Analyzing the 2026 Leadership Crisis and the Post-Sun Choe Era
Via Finterra
Topics Economy Intellectual Property Product Recall
Tickers ADDYY DECK LULU NKE ONON
Exposures COVID-19 Coal Intellectual Property
News headline image
The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
Via Finterra
Topics Initial Public Offering Intellectual Property Lawsuit
Tickers ABUS BAYRY GSK MRK MRNA PFE
Exposures COVID-19 Financial Intellectual Property
News headline image
Why This Horrible Ford Record Is Important for Investors ↗
Via The Motley Fool
Topics Product Recall
Tickers F GM
Exposures Legal Product Safety
News headline image
Why Did ATOS Stock Jump 10% In Pre-Market Today? ↗
Via Stocktwits
Tickers ATOS VTI VXF
Exposures Product Safety
News headline image
Global Development Accelerates: Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Granted Fast Track Designation by FDA
Via Newsfile
Exposures Product Safety
News headline image
Moonkie Redefines Toddler Mealtime with Launch of Award-Nominated Stainless Steel Silicone Suction Bowl
Via Get News
Topics Bonds
Exposures Debt Markets Product Safety
News headline image
Baskin Aesthetics Reveals Insights on Bioidentical Hormone Therapy Following Recent FDA Updates on Menopausal Treatments
Via Press Advantage
Exposures Product Safety
News headline image
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
Via MarketMinute
Topics Intellectual Property
Tickers LLY NVO SNY VTYX
Exposures Intellectual Property Product Safety
News headline image
A US Startup Achieves Rapid Business Growth by Purchasing Toptrue Insulated Water Bottles
Via AB Newswire
Topics Economy Supply Chain
Exposures Product Safety Supply Chain
News headline image
Top 8 Huber Needle Manufacturers and suppliers in China 2026
Via AB Newswire
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Scientific Instruments Shares How Ignoring Magnaflux Equipment Repairs Can Lead to Missed Defects and Costly Recalls
Via ReleaseWire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 ↗
Via Benzinga
Exposures Product Safety
News headline image
OS Therapies Bone Cancer Trial Data Strengthens FDA Case ↗
Via Benzinga
Exposures Product Safety
News headline image
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
Via MarketMinute
Topics Economy Intellectual Property
Tickers AMGN BMY MRK MRNA PFE
Exposures Intellectual Property Interest Rates Product Safety
News headline image
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Earnings
Tickers ABBV ISRG JNJ MRK PFE
Exposures Artificial Intelligence Financial Intellectual Property
News headline image
REMSleep Receives Expanded FDA 510(k) Clearance for DeltaWave Nasal Pillow System
Via NewMediaWire
Tickers RMSL
Exposures Product Safety
News headline image
Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives
Via NewMediaWire
Tickers SIGY
Exposures Product Safety
Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives
Via TheNewswire.com
Tickers SIGY
Exposures Product Safety
News headline image
FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks ↗
Via Benzinga
Exposures Product Safety
News headline image
DexCom's Q4 2025 Earnings: What to Expect
Via Barchart.com
Topics Economy World Trade
Exposures Product Safety Supply Chain Tariff
News headline image
Whole Foods Cofounder John Mackey Recalls Firing His Own Father From Board: &#39;I love My Dad So Much And It Hurt Him So Badly&#39; ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
MLTX Stock Erases Most Of 2025 Loses As Wall Street, Retail Bets On FDA Feedback For Sonelokimab ↗
Via Stocktwits
Tickers GS MLTX XLV
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.